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There are three basic forms of arsenic; salts, oxides, and arsine gas, all of which
are toxic to humans. Chronic inhalation of inorganic arsenic compounds is the most
common cause of industrial arsenic poisoning; however, arsenic also enters the body via
ingestion and absorption through the skin. Trivalent arsenic (arsenite) is more toxic than
pentavalent arsenic (arsenate) by several orders of magnitude, yet the arsenates are better
absorbed and may be converted to arsenites once in the body.
Arsenicals are found in pesticides, herbicides, rat poisons, semiconductors, and
wood preservatives, and are often by-products of some industrial metallurgical
applications (e.g., copper smelting). Additionally, arsenic compounds have been found
in seafood and as an ingredient in some homeopathic medications. Arsenic binds with
the sulfhydryl groups of the body's proteins, interfering with the ability of various
enzymes to catalyze crucial cell metabolism. Arsenic has also been shown to increase
chromosomal breakage and therefore may be teratogenic, mutagenic, and carcinogenic.
Acute clinical symptoms from arsenic exposure can vary widely depending on the
type and chemical state of the arsenic involved, age and physical condition of the subject,
and the duration and dose of the exposure. Symptoms of acute poisoning may occur
within minutes or be delayed for several hours. Initially, acute exposure to arsenic can
be irritating to both the skin and mucous membranes of the respiratory system and
gastrointestinal tract. When there is a primary inhalation of an arsenic-containing
substance, much of the substance is actually ingested as accumulated inhaled material in
the mucous secretions of the upper respiratory system are swallowed. Arsenicals can
cause damage to capillary walls rendering them quite friable. Inhalation can lead to
nosebleeds and perforation of the nasal sputum as well as causing small hemorrhages on
the mucous membranes of the entire respiratory tree and gastrointestinal tract, and
causing hemorrhages directly on exposed skin. Symptoms of nausea, vomiting (often
hematemesis), colicky abdominal pain, diarrhea (often bloody), thirst, dizziness, muscle
cramps, and burning of the mouth result from inflammation of the gastrointestinal tract
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mucosa. Similar damage can occur to the brain's capillaries if a large enough dose of
arsenic is ingested or inhaled, resulting in peri-capillary edema, intraluminal dotting and,
eventually, infarct. The heart can be affected acutely, as demonstrated by
electrocardiogram changes which principally include tenting and elevation of the T-wave,
and can progress with chronic exposure onto QT prolongation. Death is frequently rapid
and occurs through disseminated central nervous system damage, marked weakness and
muscle paralysis, liver and kidney damage, and vasomotor collapse.
Arsine gas, unlike arsenic, preferentially binds to hemoglobin causing massive
hemolysis, hemoglobinuria, jaundice, and subsequent renal failure. Inhalation of very
small quantities of arsine gas can be rapidly fatal. For example, inhaling 250 ppm (parts
per million) of arsine gas is instantly fatal, while exposure to 25-50 ppm over 30 minutes
is lethal.
About five weeks after an acute exposure to arsenic, the Mees line, a transverse
white line in the nails, 1 to 2 mm in width, becomes visible above the cuticle. The lines
advance at about 1 mm per week, allowing estimation of the time of acute exposure.
Chronic exposure to low levels of arsenic compounds may result in small,
superficial ulcers in the gastrointestinal tract or affect other mucous membranes, causing
keratoconjunctivitis, corneal necrosis, and rhinopharyngeal-tracheobronchitis. Hepatic
enlargement, frequently with few liver function abnormalities, has been observed.
Peripheral neuritis, in a "stocking glove" distribution, resulting in motor dysfunction and
paresthesia can occur. Chronic skin changes are the best recognized result of long-term
arsenic exposure, with facial edema, erythema, desquamation, and hyperpigmentation of
resultant scars frequent signs. The hyperpigmentation frequently also occurs over the
neck, armpits, and nipples. Hyperkeratosis of the palms and soles often are apparent,
which can progress occasionally to skin cancers. Painful hot, swollen feet that make
walking very difficult are readily diagnosable symptoms of chronic arsenic exposure.
Various degrees of bone marrow suppression have been reported, leading to depletion
of specific cell lines, or pancytopenia.
Quantitative 24-hour urine collections seem to be the most reliable laboratory
measurement of arsenic poisoning. After a single dose of arsenic, most urinary excretion
occurs over the first four days, with virtually negligible levels found after the sixth day.
The upper limit of normal for a 24-hour urine arsenic is 100 #g (micrograms)/24 hours.
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Blood arsenic levels (with normal less than 7 /_g/100 ml) do not correlate well with
chronic exposure, although they may help to confirm diagnosis after an acute exposure.
Spot urine arsenic levels have been unreliable and may be falsely elevated after eating
seafood, for example, or other arsenic-containing substances. Hair and nail analysis for
arsenic is also inconsistent and unreliable.
Purpose
The purpose of the Arsenic Surveillance Program at the NASA Lewis Research
Center shall be to:
.
,
.
Identify any Lewis employee who is exposed to arsenic above the action
level, at the physician's discretion;
Educate that employee about the nature of arsenic, the proper use of
respiratory protection and protective clothing, and appropriate sanitation
practices to be used when handling arsenic-containing substances;
Monitor those employees by obtaining an extensive past medical and
occupational exposure history, and then perform periodic physical exams
with twenty-four (24) hour urine collections for arsenic concentrations to
detect early signs and symptoms of arsenic poisoning. When arsenic
exposure is anticipated, a baseline physical exam with a 24-hour urine
collection for arsenic shall be obtained.
Medical Surveillance
The specifics of the Medical Surveillance Program for Arsenic Exposure at the
NASA Lewis Research Center will fulfill the criteria required by OSHA and will
incorporate recommendations from NIOSH.
The permissible exposure limit (PEL) for arsenic-containing compounds, as
defined by OSHA, are:
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Inorganic arsenic
Organic arsenic
Arsine gas
0.010 mg/m 3 (10/_g/m a)
0.5 mg/m 3 (500 #g/m 3)
0.2 mg/m 3 (0.05 ppm)
All PELs are based on an 8-hour TWA. There are no specified STEL or Ceiling Limits
for any arsenic-containing substance.
Of greatest clinical importance in an occupational setting are inorganic arsenic
substances. The Action Level (AL) for inorganic arsenic compounds is defined as 0.005
mg/m 3 (or 5 #g/ma). Medical surveillance for arsenic exposure is required for
employees exposed at or above the AL for 30 days or more per year.
NASA employees identified by the Office of Environmental Programs as having
been exposed to the AL for arsenic will be entered into the medical surveillance
program. As soon as possible, these employees will need:
o Medical and Work Histories, with special attention to:
- dietary habits
- previous occupational exposures
smoking history
respiratory symptoms
muscle weakness, paresthesia, loss of sensation in extremities
skin pigmentations (erythema or hyperpigmentation)
skin changes, especially of the palms or soles.
. A Complete Physical Exam, with special attention to:
Skin (color, hyperkeratosis, hyperpigmented lesions, fingernails)
Mucous membranes (nose, mouth, GI tract, respiratory system)
Abdominal exam (tenderness, hepatomegaly)
- Neurologic exam (strength, sensation, DTRs).
° Laboratory Exam, to include:
- Chest X-ray
- CBC with differential
- Serum chemistries (BUN, Creatinine, LFTs, bilirubin)
- Urinalysis with microscopy
- EKG (T-wave abnormalities, QT prolongation)
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Sputum cytology (not recommended in employees under 45 years of
age with fewer than 10 years of exposure under the AL)
Stool guaiac, where acute exposure is suspected
Abdominal X-rays (KUB), where ingestion is suspected
24-hour urine collection for arsenic (normal < 100/zg).
The above evaluation will need to be repeated, at least within seven (7) days if
the 24-hour urine arsenic is greater than 100 tt_. The frequency at which this exam
should be repeated is left to the discretion of the physician, and is based on clinical
symptomatology, physical signs, and laboratory abnormalities.
In the event that the Office of Environmental Programs determines that an
employee is at an increased risk of arsenic exposure at or above the AL because of the
nature of the employee's job or the potential presence of arsenic-containing compounds
in the work environment, then that employee shall receive the above evaluation as a
baseline exam before potential exposure, followed by annual arsenic surveillance exams,
until such time as the OEP determines that the employee is no longer at risk for arsenic
exposure.
If there is a risk of _ exposure to arsenic in an employee's work environment,
regardless if this potential exposure is deemed to be above or below the AL for arsenic
as determined by the OEP, then that employee will receive annual arsenic surveillance
exams.
Upon retirement or termination of employment, an employee who has been
involved in an ongoing arsenic medical surveillance program is entitled to a final arsenic
surveillance exam with the appropriate laboratory studies. The Occupational Medicine
Service will not continue surveillance of an individual once they have retired or are no
longer employed by NASA. During the final examination, recommendations will be
given to the individual for continued medical surveillance, if necessary, to be performed
by the individual's private physician.
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Summary Table for Frequency of Arsenic Surveillance Exams
Anticipated exposure to arsenic
at or above the AL
Baseline arsenic surveillance exam
before exposure
Acute exposure to arsenic at or
above the PEL
Immediate exam, if possible, with
appropriate follow-up as dictated by
physical and laboratory findings
Work environment with chronic
arsenic levels at or above the
AL for 30 days or more per year:
a. < 45 years old with < 10 years
exposure
b. >/=45 years old regardless of
duration of exposure
c. >/= 10 years exposure regardless
of age
Annual Exam
Semi-annual exam (every 6 months)
Semi-annual exam (every 6 months)
Any risk of arsenic exposure Annual exam
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